Aspen still hoping for sales of SA’s home-grown vaccine
Group gets no orders for its Aspenovax, despite many calls over past year for Africa to develop a vaccine capacity
19 October 2022 - 17:41
SA’s biggest pharmaceutical manufacturer, Aspen Pharmacare, is still holding out for orders of its own-branded Covid-19 vaccine, Aspenovax, hoping the need for boosters will shore up demand.
Aspen clinched a deal with US drug maker Johnson & Johnson in late 2020 to bottle its Covid-19 vaccine at its Gqeberha facility, and then reached a licensing agreement to enable it to make Aspenovax for the African market. ..
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.